Floatz logo

Anti-Cd7 Car-Pnk Cells

Hepatosplenic T-cell Lymphoma

PersonGen BioTherapeutics (Suzhou) Co., Ltd.Cell therapyPhase 1/2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Hepatosplenic T-cell Lymphoma cohort.

Asset / SponsorPhaseRating
Fludarabine
National Cancer Institute (NCI)
Phase 2BBB
PREDNISONE TABLETS
City of Hope Medical Center
Phase 4BBB
Inno-206
National Cancer Institute (NCI)
Phase 4BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BBB
Inno-206
National Cancer Institute (NCI)
Phase 4BBB

View all 50 →

Same molecule, other indications

Anti-Cd7 Car-Pnk Cells is also rated in:

T-cell large granular lymphocyte leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
CCC
Indicative ·
48 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →